Several mechanisms for which LRRK2 could display a tumor-suppressor function have been described, most notably p53 phosphorylation and p21 induction [36], JNK activation [37], and RCAN1 phosphorylation [38]. The gene discussed is LRRK2; the disease is neoplasm.